Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company engages in the manufacturing, importing, and marketing of branded generic pharmaceutical products; AND import and marketing of nutritional products. It imports and markets diagnostic equipment, molecular devices, and testing kits; and manufactures and markets diabetes care and general healthcare products. The company offers its products under the Brufen, Surbex Z, Duphaston, Arinac, Ensure, Pediasure, Glucerna, FreeStyle Libre, and Alinity brand names. It exports its products. The company was founded in 1888 and is based in Karachi, Pakistan. Abbott Laboratories (Pakistan) Limited operates as a subsidiary of Abbott Asia Investments Limited.
Metrics to compare | ABBT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABBTPeersSector | |
---|---|---|---|---|
P/E Ratio | 20.0x | 22.5x | −0.5x | |
PEG Ratio | 0.12 | 0.20 | 0.00 | |
Price/Book | 4.4x | 3.1x | 2.6x | |
Price / LTM Sales | 1.5x | 2.0x | 3.2x | |
Upside (Analyst Target) | - | 25.9% | 41.9% | |
Fair Value Upside | Unlock | 16.0% | 4.3% | Unlock |